Plumbline Life Sciences, Inc. (XKON:222670)

South Korea · Delayed Price · Currency is KRW

6,190.00

+50.00 (0.81%)

Last updated: Sep 15, 2025, 12:00 PM KST

Plumbline Life Sciences Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2014
Period Ending	Dec '14 Dec 31, 2014
Selling, General & Admin	348.96
Operating Expenses	590.62
Operating Income	-590.62
Interest Expense	-42.12
Interest & Investment Income	0.24
Currency Exchange Gain (Loss)	-140.48
Other Non Operating Income (Expenses)	-1.01
Pretax Income	-773.99
Net Income	-773.99
Net Income to Common	-773.99
Shares Outstanding (Basic)	1
Shares Outstanding (Diluted)	1
EPS (Basic)	-771.00
EPS (Diluted)	-771.00
Free Cash Flow	-338.61
Free Cash Flow Per Share	-337.30
EBITDA	-348.84
D&A For EBITDA	241.78
EBIT	-590.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.